Blocking egg development in malaria mosquito could reduce transmission of the disease
For immediate release: October 29, 2013
Boston, MA – A new study led by Harvard School of Public Health (HSPH) and University of Perugia (UNIPG) researchers has shown that egg development in the mosquito species primarily responsible for spreading malaria depends on a switch in the female that is turned on by a male hormone delivered during sex. Blocking the activation of this switch could impair the ability of the species, Anopheles gambiae, to reproduce, and may be a viable future strategy for mosquito and malaria control.
The study appears online October 29, 2013 in PLoS Biology.
“These findings represent a significant step forward in our understanding of how these devastating malaria vectors reproduce,” said Flaminia Catteruccia, associate professor of immunology and infectious diseases at HSPH and UNIPG.
Malaria is a leading cause of death in tropical and subtropical regions. According to the U.S. Centers for Disease Control and Prevention, malaria claims nearly 660,000 lives per year, 90% of them in Africa—and most of them children. There were an estimated 216 million malaria cases worldwide in 2010, mostly among pregnant women and children.
The researchers based their investigation on existing knowledge about Anopheles gambiae, a highly efficient vector of the malaria parasite because those mosquitoes primarily feed on human blood and have a remarkably high reproductive rate.
The researchers studied the interaction between a steroid hormone called 20-hydroxy-ecdysone, or 20E—which is transferred from the male to the female mosquito during mating—and a female “Mating-Induced Stimulator of Oogenesis,” or MISO, protein. (Oogenesis is the creation of an egg cell.)
They used chemical techniques to suppress MISO’s functioning in female mosquitoes and found that doing so reduced egg development. They also found that MISO and 20E interact in the female mosquito’s reproductive tract. Further, they identified the pathway through which 20E affects MISO. The 20E-MISO interaction boosts the accumulation of lipids in the ovaries, leading to a more rapid and higher production of eggs.
The researchers found that egg development depends on a switch—the MISO protein—in the female that is turned on by a male hormone delivered during sex. Male-transferred 20E essentially acts as a “mating signal” for the female to produce more eggs. “How males contributed to egg development had been previously unknown; with the identification of the molecular players of this male-female interaction we can now find ways to switch off the signal and prevent females from reproducing,” said Catteruccia.
This new finding holds promise for the development of new tools for controlling malaria-transmitting mosquito populations, the researchers said.
“This is the first time, in any insect species, that a male hormone has been shown to directly interact with a female protein and alter the ability of the female to reproduce,” said co-author Francesco Baldini, a UNIPG graduate student who performed part of the analyses as a visiting scientist at HSPH.
Other HSPH researchers from the Department of Immunology and Infectious Diseases who participated in the study included Paolo Gabrieli, a visiting scientist from UNIPG; Adam South, research fellow; and Clarissa Valim, research scientist.
Support for the study came from the European Research Council FP7 ERC Starting Grant project ‘Anorep’ (grant ID: 260897; http://erc.europa.eu/), by a Wellcome Trust grant (grant ID: 093553; http://www.wellcome.ac.uk/), and from the HSPH Department of Immunology and Infectious Diseases to Catteruccia.
“The interaction between a sexually transferred steroid hormone and a female protein regulates oogenesis in the malaria mosquito Anopheles gambiae,” Francesco Baldini, Paolo Gabrieli, Adam South, Clarissa Valim, Francesca Mancini, Flaminia Catteruccia, PLoS Biology, online October 29, 2013
For more information:
Harvard School of Public Health brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. As a community of leading scientists, educators, and students, we work together to take innovative ideas from the laboratory and the classroom to people’s lives—not only making scientific breakthroughs, but also working to change individual behaviors, public policies, and health care practices. Each year, more than 400 faculty members at HSPH teach 1,000-plus full-time students from around the world and train thousands more through online and executive education courses. Founded in 1913 as the Harvard-MIT School of Health Officers, the School is recognized as the oldest professional training program in public health.